Norcod (NCOD) Company presentation summary
Event summary combining transcript, slides, and related documents.
Company presentation summary
12 May, 2026Strategic positioning and market environment
Leading producer of premium Atlantic Cod with eight farming sites and one harvesting facility in Norway, targeting 8,000t WFE annual harvest volume and aiming for 25,000t WFE in the medium term.
Market for farmed cod is strong due to a 62% drop in wild cod quotas from 2021 to 2025, driving higher prices and demand for year-round, high-quality supply.
Listed on Euronext Growth since 2020 with a NOK 770m market cap as of May 2026.
Strategic partnerships with major seafood distributors and retailers enable global reach and rapid delivery to key markets.
Operational performance and biological advancements
Over 25 years of R&D have led to the 9th generation of fry, showing strong biological results and high survival rates (up to 87% in 2025).
High superior quality share and low feed conversion ratios (FCR) support cost efficiency and premium pricing.
Key biological risks such as escapes, maturation, and mortality have been addressed with upgraded nets, optimized lighting, and improved vaccines.
Strategic site locations offer optimal conditions, contributing to consistent year-round supply and strong biological performance.
Financial development and growth strategy
NOK 1.4bn raised in equity since 2018, with major investments in infrastructure and R&D; now entering a capex-light phase.
EBITDA expected to turn positive in H2 2026, with cost per kg targeted at NOK 43 at 25,000t WFE production.
Illustrative project economics show potential EBIT per kg of NOK 15–26 at 25,000t WFE, with a 22% ROCE at NOK 80/kg price.
Scaling up production leverages economies of scale, reducing costs for fry, juveniles, and other operating expenses.
Latest events from Norcod
- Scaling to 25,000t WFE, targeting profitability in 2026, with premium branding and sustainability focus.NCOD
Company presentation30 Apr 2026 - Revenue up 6% to NOK 91m, EBIT margin improved 33%, and losses narrowed despite lower volumes.NCOD
Q2 20254 Mar 2026 - Revenue up 12% and sales prices up 35%, but extraordinary mortality drove operating loss.NCOD
Q4 202526 Feb 2026 - Revenue up 121% and operating loss down 34% as harvests and premium market demand surge.NCOD
Q2 202423 Jan 2026 - Revenue up 47%, operating loss down 66%, and NOK 300M in new funding committed.NCOD
Q4 202423 Dec 2025 - Revenue up 17.6% YoY; strategic investment and premium pricing drive growth outlook.NCOD
Q3 202513 Nov 2025 - Revenue up 63% and operating loss narrowed as funding and growth plans advance.NCOD
Q1 202510 Sep 2025 - Q3 revenue surged 229% year-over-year, but losses rose due to heatwave-driven mortality.NCOD
Q3 202413 Jun 2025 - Revenue down 5% but operating loss halved; Norcod boosts equity and enters China.NCOD
Q1 202413 Jun 2025